Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Ann C. Childress, Marina Komolova & F. Randy Sallee. (2019) An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology 15:11, pages 937-974.
Read now
Read now
Joshua Caballero, Edress H Darsey, Faith Walters & Heidi W Belden. (2017) Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists. Integrated Pharmacy Research and Practice 6, pages 163-171.
Read now
Read now
Ann Childress. (2017) The safety of extended-release drug formulations for the treatment of ADHD. Expert Opinion on Drug Safety 16:5, pages 603-615.
Read now
Read now
Ann C. Childress. (2016) Methylphenidate HCL for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy 17:8, pages 1171-1178.
Read now
Read now
Ann Childress & Floyd R Sallee. (2013) The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD. Expert Review of Neurotherapeutics 13:9, pages 979-988.
Read now
Read now
Ann C Childress & Floyd R Sallee. (2012) The use of lisdexamfetamine dimesylate for the treatment of ADHD. Expert Review of Neurotherapeutics 12:1, pages 13-26.
Read now
Read now
Ann C. Childress, F. Randy Sallee & Sally A. Berry. (2011) Single-Dose Pharmacokinetics of NWP06, an Extended-Release Methylphenidate Suspension, in Children and Adolescents with ADHD. Postgraduate Medicine 123:5, pages 80-88.
Read now
Read now
Josephine Elia, Zoe Wilson, Lilly Sehgal La Porta, Sibel A Algon, Matthew L Prowler, Shanique T Cartwright, Patricia A McKenna, Seth Laracy, Toshinobu Takeda & Karin Borgmann-Winter. (2011) Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder. Expert Review of Clinical Pharmacology 4:3, pages 311-328.
Read now
Read now
Articles from other publishers (11)
Takayuki Yoshida & Hiroyuki Kojima. (2023) Oral Drug Delivery Systems Applied to Launched Products: Value for the Patients and Industrial Considerations. Molecular Pharmaceutics 20:11, pages 5312-5331.
Crossref
Crossref
Alessandro Zuddas & Sara Carucci. 2020. Tasman’s Psychiatry. Tasman’s Psychiatry
1
41
.
Ann C. Childress. (2022) Stimulants. Child and Adolescent Psychiatric Clinics of North America 31:3, pages 373-392.
Crossref
Crossref
Roberto Gomeni, Marina Komolova, Bev Incledon & Stephen V. Faraone. (2020) Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 40:4, pages 350-358.
Crossref
Crossref
Ronald SteingardSarper TaskiranDaniel F. ConnorJohn S. MarkowitzMark A. Stein. (2019) New Formulations of Stimulants: An Update for Clinicians. Journal of Child and Adolescent Psychopharmacology 29:5, pages 324-339.
Crossref
Crossref
Floyd R. Sallee, Donna R. Palumbo, Richat Abbas, Sally A. Berry, Shivanand P. Puthli & Kalyan K. Kathala. (2017) Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended-Release Oral Suspension for Attention Deficit Hyperactivity Disorder. Clinical Pharmacology in Drug Development 6:5, pages 476-483.
Crossref
Crossref
Samuele Cortese, Giulia D’Acunto, Eric Konofal, Gabriele Masi & Benedetto Vitiello. (2017) New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability. CNS Drugs 31:2, pages 149-160.
Crossref
Crossref
Richat Abbas, Donna Palumbo, Faith Walters, Heidi Belden & Sally A. Berry. (2016) Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared With Immediate-release Methylphenidate Chewable Tablet. Clinical Therapeutics 38:5, pages 1151-1157.
Crossref
Crossref
Xiaoxia Yang, Suzanne M. Morris, Jeffery M. Gearhart, Christopher D. Ruark, Merle G. Paule, William Slikker, Donald R. Mattison, Benedetto Vitiello, Nathan C. Twaddle, Daniel R. Doerge, John F. Young & Jeffrey W. Fisher. (2014) Development of a Physiologically Based Model to Describe the Pharmacokinetics of Methylphenidate in Juvenile and Adult Humans and Nonhuman Primates. PLoS ONE 9:9, pages e106101.
Crossref
Crossref
Priti Purushothaman. (2013) What's New with Stimulants?. Child and Adolescent Psychopharmacology News 18:4, pages 1-8.
Crossref
Crossref
Sharon B. WigalAnn C. ChildressHeidi W. BeldenSally A. Berry. (2013) NWP06, an Extended-Release Oral Suspension of Methylphenidate, Improved Attention-Deficit/Hyperactivity Disorder Symptoms Compared with Placebo in a Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology 23:1, pages 3-10.
Crossref
Crossref